Solution Group going regional


Upon obtaining the approval, Solution Group deputy group managing director Datuk Mohd Nazlee Kamal (file pic) told StarBiz, the company would produce between 30 million and 40 million doses for this year. Some of the vaccines would also be exported to South-East Asian countries.

KUALA LUMPUR: Solution Group Bhd, which has inked a deal with China’s CanSino Biologics Inc for the distribution of the Covid-19 vaccines in Malaysia, has started to plan for bigger things ahead.

The engineering and biopharmaceuticals company is looking to export the vaccines to the South-East Asia region.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Quill Group, China Mobile International explore AI, data centre opportunities in Malaysia
Sapura Resources swings to the black in 2Q26
Inta Bina secures RM221.08mil contract from Mitraland
Infomina secures RM62.65mil contract from Malaysian financial institution
Ringgit ends higher against major currencies, eases versus US dollar
Superlon appoints Jeremy Liu as CEO
LB Group expands Malaysia footprint with RM1bil facility in Kedah
ASteel independent adviser recommends shareholders reject 7.5 sen takeover offer
UUE Holdings secures RM29.8mil Singapore power cable contracts�
OpenMove AI appoints Steven Lim as Group CEO

Others Also Read